首页> 外国专利> HSA-MIR124 AND FAM19A4, MOLECULAR DIAGNOSTIC MARKERS FOR HPV-INDUCED INVASIVE CANCERS AND THEIR HIGHLIGHTS

HSA-MIR124 AND FAM19A4, MOLECULAR DIAGNOSTIC MARKERS FOR HPV-INDUCED INVASIVE CANCERS AND THEIR HIGHLIGHTS

机译:HSA-MIR124和FAM19A4,HPV诱导的浸润性癌的分子诊断标志物及其亮点

摘要

The invention relates to method for detecting HPV-induced high-grade precancerous lesions and HPV-induced invasive cancers, said method comprising detection of hypermethylation in the PRDM14 and/or FAM19A4 gene in a cell whereby such hypermethylation indicates the presence of HPV-induced precursor lesions with invasive potential and HPV-induced invasive cancers. The invention further comprises the use of the PRDM14 and/or FAM19A4 gene in such a method and a testkit for the detection of PRDM14 and/or FAM19A4 methylation.
机译:本发明涉及检测HPV诱导的高级别癌前病变和HPV诱导的浸润性癌症的方法,所述方法包括检测细胞中PRDM14和/或FAM19A4基因中的高甲基化,由此这种高甲基化表明存在HPV诱导的前体具有潜在侵袭性的病变和HPV引起的侵袭性癌症。本发明进一步包括PRDM14和/或FAM19A4基因在用于检测PRDM14和/或FAM19A4甲基化的这种方法和测试试剂盒中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号